The efficacy of the Be82 gene product fused with glutathione S-transferase (GST/Be82) in an enzymelinked immunosorbent assay (ELISA) for the diagnosis of Babesia equi infection was reported previously (H. Hirata et al., J. Clin. Microbiol. 40:1470-1474, 2002). However, the ELISA with the GST/Be82 antigen cross-reacted with Babesia caballi-infected horse sera, despite the high rate of detection of B. equi. These results suggested that GST/Be82 has an antigen in common with B. caballi or antigenicity similar to that of B. caballi. In the present study, we constructed a series of five clones with deletions in the Be82 gene product, each of which was fused with GST, and used them in ELISAs in order to overcome the cross-reactivity seen with B. caballi. One of the deletion clones, a clone with a deletion of the Be82 gene from positions 236 to 381 (Be82/236-381), specifically and sensitively detected B. equi-infected horse sera without cross-reactivity with B. caballi-infected horse sera. Assays with clones from which other gene products were deleted showed decreased sensitivities or remained nonspecific for the detection of B. equi-infected horse sera. These results suggest that the Be82/236-381 gene product is a novel antigen for the diagnosis of B. equi infection in horses.Equine piroplasmosis is an economically important tickborne protozoan disease of horses that has been reported worldwide. The disease is caused by blood parasites named Babesia equi and Babesia caballi (9). Babesia parasites destroy host erythrocytes and induce fever, anemia, and icterus in infected horses (6). These parasites are usually detectable in blood smears only during the acute stage of the infection. In contrast, horses that recover from disease continue to be parasite carriers, and these carriers as well as previously exposed animals should be identified serologically (3). Japan is considered free of equine piroplasmosis, but the number of imported horses has increased recently. Therefore, it is urgent that a highly specific and sensitive system for the diagnosis of equine piroplasmosis be developed to avoid the introduction of infected or carrier horses into Japan.We recently reported on the efficacy of the Be82 gene product with glutathione S-transferase (GST/Be82) in an enzyme-linked immunosorbent assay (ELISA) for the diagnosis of B. equi infection (4). The ELISA with the Be82 gene antigen was shown to be highly specific only for B. equi antibodies when a cutoff value was set at a relatively high level (4). Although the number of serum samples tested was insufficient to evaluate whether the cross-reactivity of the GST/Be82 antigen with B. caballi-infected sera was authentic, there was a possibility that the B. equi Be82 protein might have an antigen in common with B. caballi or have antigenicity similar to that of B. caballi. Therefore, in this study we constructed a deletion series of the Be82 gene products and evaluated their sensitivities and specificities in ELISAs for the diagnosis of B. equi infection in horses.
MATERIALS AND...